Nanjing Hicin Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 104.56 million compared to CNY 117.2 million a year ago. Revenue was CNY 104.56 million compared to CNY 117.2 million a year ago.

Net income was CNY 13.36 million compared to CNY 12.21 million a year ago. Basic earnings per share from continuing operations was CNY 0.1113 compared to CNY 0.1018 a year ago. Diluted earnings per share from continuing operations was CNY 0.1113 compared to CNY 0.1018 a year ago.